Ibuprofen 200 Mg
NDC Package 71309-111-50
Package Information
Ibuprofen 200 Mg is do not take more than directedthe smallest effective dose should be usedadults and children 12 years and over: take 1 tablet every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 tablet, 2 tablets may be useddo not exceed 6 tablets in 24 hours, unless directed by a doctorchildren under 12 years: ask a doctor. Marketed by Safrel Pharmaceuticals, Llc., this product is identified by NDC 71309-111 and is authorized under FDA application ANDA079174.
Identification & Billing
- RxCUI: 310965 - ibuprofen 200 MG Oral Tablet
- RxCUI: 310965 - ibuprofen 200 MG (as ibuprofen sodium 256 MG) Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71309 - Safrel Pharmaceuticals, Llc.
- 71309-111 - Ibuprofen 200 Mg
- 71309-111-50 - 50 BOTTLE in 1 CARTON / 2 TABLET, COATED in 1 BOTTLE
- 71309-111 - Ibuprofen 200 Mg
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71309-111). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71309-111-50 identifies a specific commercial package of 50 bottle in 1 carton / 2 tablet, coated in 1 bottle of Ibuprofen 200 Mg, labeled by Safrel Pharmaceuticals, Llc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Safrel Pharmaceuticals, Llc. on January 01, 2011. The current certification is valid through December 31, 2023.
How is this Safrel Pharmaceuticals, Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71309011150. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.